Company
AccuRna, Inc.
AccuRna develops simple and robust drug delivery system (DDS) for nucleic acid therapeutics.
Also known as AccuRna
- Status
- Mergedas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
- Founded
- 2015
- Legal name
- AccuRna Inc
Claim, correct or request removal
Record updated 29 September 2026
About
AccuRna is pioneering unique drug delivery system (DDS) for nucleic acid therapeutics, both of short chain including ASO, siRNA, miRNA and long chain, mRNA as a therapeutic drug.
Funding snapshot
- Latest round
- Undisclosed2019-12-23
Funding rounds
- Additional Financing Round
- 2019-12-23
- Round, 2018
- 2018-01-17
About the company
- Status notes
- 株式交換による吸収合併のお知らせ (Japanese only)
Products
- Other
- drug delivery system (DDS) for nucleic acid therapeutics
Loading relationship preview